<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="dict8/PMC7320681/results/search/disease/results.xml">
  <result pre="10.1016/j.transci.2020.102856102856 : Article Immunomodulation for the management of corona virus" exact="disease" post="(COVID-19) KiprovDobridkiprovcai@aol.com*ConboyMichael J.conboymj@berkeley.eduConboyIrina M.iconboy@berkeley.edu[], âŽCorresponding author. dkiprovcai@aol.com pmc-release: 2020-6-6ppub:"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="as the COVID-19 resource centre remains active. The corona virus" exact="disease" post="(COVID-19) has caused a global health and economic crisis."/>
  <result pre="convalescent plasma collected from people who have fully recovered from" exact="infection" post="contains antibodies against the infectious agent. Convalescent plasma provides"/>
  <result pre="who have fully recovered from infection contains antibodies against the" exact="infectious" post="agent. Convalescent plasma provides passive immunity and has been"/>
  <result pre="used for the prophylaxis and treatment of a number of" exact="infectious diseases," post="including recent epidemics with SARS-Cov-1, Ebola and Middle Eastern"/>
  <result pre="diseases, including recent epidemics with SARS-Cov-1, Ebola and Middle Eastern" exact="Respiratory" post="Syndrome (MERS) [1]. Small studies from China have demonstrated"/>
  <result pre="including recent epidemics with SARS-Cov-1, Ebola and Middle Eastern Respiratory" exact="Syndrome" post="(MERS) [1]. Small studies from China have demonstrated that"/>
  <result pre="recovered from COVID-19 is safe and results in reduction of" exact="viral" post="load and improved clinical outcome. This prompted the FDA"/>
  <result pre="from COVID-19 and account for the majority of the deaths." exact="Systemic" post="chronic inflammation is believed to be the major cause"/>
  <result pre="COVID-19 and account for the majority of the deaths. Systemic" exact="chronic" post="inflammation is believed to be the major cause of"/>
  <result pre="regulation of the immune response that leads to an increased" exact="susceptibility to" post="viral infections and weakened response to vaccines. Collateral damage"/>
  <result pre="the immune response that leads to an increased susceptibility to" exact="viral" post="infections and weakened response to vaccines. Collateral damage from"/>
  <result pre="immune response that leads to an increased susceptibility to viral" exact="infections" post="and weakened response to vaccines. Collateral damage from chronic"/>
  <result pre="viral infections and weakened response to vaccines. Collateral damage from" exact="chronic" post="inflammation is oxidative stress [2]. Experimental studies in rodents"/>
  <result pre="a beneficial effect in sepsis associated with severe inflammatory response" exact="syndrome" post="(SIRS) [5]. And recently, TPE has been successfully used"/>
  <result pre="been successfully used in the treatment of severe cytokine release" exact="syndrome" post="after Chimera Antigen Receptor T cell (CAR-T) infusion. TPE"/>
 </snippets>
</snippetsTree>
